Global Biopharmaceutical Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 101

Report ID: 3057

A biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.
North America has the highest market share for the estimated period owing to presence of sophisticated healthcare infrastructure, growing geriatric population base and increased healthcare expenditure in the region. Asia Pacific is expected to register the highest growth rate for the forecasted period mainly due to presence of unmet market opportunities in the region.
In 2018, the global Biopharmaceutical market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Biopharmaceutical status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biopharmaceutical development in United States, Europe and China.

The key players covered in this study
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck

Market segment by Type, the product can be split into
Monoclonal Antibodies
Interferon
Erythropoietin
Insulin
Other

Market segment by Application, split into
Tumor
Diabetes
Cardiovascular
Hemophilia
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Biopharmaceutical status, future forecast, growth opportunity, key market and key players.
To present the Biopharmaceutical development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Biopharmaceutical are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Biopharmaceutical Market Size Growth Rate by Type (2014-2025)
1.4.2 Monoclonal Antibodies
1.4.3 Interferon
1.4.4 Erythropoietin
1.4.5 Insulin
1.4.6 Other
1.5 Market by Application
1.5.1 Global Biopharmaceutical Market Share by Application (2014-2025)
1.5.2 Tumor
1.5.3 Diabetes
1.5.4 Cardiovascular
1.5.5 Hemophilia
1.5.6 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Biopharmaceutical Market Size
2.2 Biopharmaceutical Growth Trends by Regions
2.2.1 Biopharmaceutical Market Size by Regions (2014-2025)
2.2.2 Biopharmaceutical Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Biopharmaceutical Market Size by Manufacturers
3.1.1 Global Biopharmaceutical Revenue by Manufacturers (2014-2019)
3.1.2 Global Biopharmaceutical Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Biopharmaceutical Market Concentration Ratio (CR5 and HHI)
3.2 Biopharmaceutical Key Players Head office and Area Served
3.3 Key Players Biopharmaceutical Product/Solution/Service
3.4 Date of Enter into Biopharmaceutical Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Biopharmaceutical Market Size by Type (2014-2019)
4.2 Global Biopharmaceutical Market Size by Application (2014-2019)

5 United States
5.1 United States Biopharmaceutical Market Size (2014-2019)
5.2 Biopharmaceutical Key Players in United States
5.3 United States Biopharmaceutical Market Size by Type
5.4 United States Biopharmaceutical Market Size by Application

6 Europe
6.1 Europe Biopharmaceutical Market Size (2014-2019)
6.2 Biopharmaceutical Key Players in Europe
6.3 Europe Biopharmaceutical Market Size by Type
6.4 Europe Biopharmaceutical Market Size by Application

7 China
7.1 China Biopharmaceutical Market Size (2014-2019)
7.2 Biopharmaceutical Key Players in China
7.3 China Biopharmaceutical Market Size by Type
7.4 China Biopharmaceutical Market Size by Application

8 Japan
8.1 Japan Biopharmaceutical Market Size (2014-2019)
8.2 Biopharmaceutical Key Players in Japan
8.3 Japan Biopharmaceutical Market Size by Type
8.4 Japan Biopharmaceutical Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Biopharmaceutical Market Size (2014-2019)
9.2 Biopharmaceutical Key Players in Southeast Asia
9.3 Southeast Asia Biopharmaceutical Market Size by Type
9.4 Southeast Asia Biopharmaceutical Market Size by Application

10 India
10.1 India Biopharmaceutical Market Size (2014-2019)
10.2 Biopharmaceutical Key Players in India
10.3 India Biopharmaceutical Market Size by Type
10.4 India Biopharmaceutical Market Size by Application

11 Central & South America
11.1 Central & South America Biopharmaceutical Market Size (2014-2019)
11.2 Biopharmaceutical Key Players in Central & South America
11.3 Central & South America Biopharmaceutical Market Size by Type
11.4 Central & South America Biopharmaceutical Market Size by Application

12 International Players Profiles
12.1 Roche
12.1.1 Roche Company Details
12.1.2 Company Description and Business Overview
12.1.3 Biopharmaceutical Introduction
12.1.4 Roche Revenue in Biopharmaceutical Business (2014-2019)
12.1.5 Roche Recent Development
12.2 Amgen
12.2.1 Amgen Company Details
12.2.2 Company Description and Business Overview
12.2.3 Biopharmaceutical Introduction
12.2.4 Amgen Revenue in Biopharmaceutical Business (2014-2019)
12.2.5 Amgen Recent Development
12.3 AbbVie
12.3.1 AbbVie Company Details
12.3.2 Company Description and Business Overview
12.3.3 Biopharmaceutical Introduction
12.3.4 AbbVie Revenue in Biopharmaceutical Business (2014-2019)
12.3.5 AbbVie Recent Development
12.4 Sanofi-Aventis
12.4.1 Sanofi-Aventis Company Details
12.4.2 Company Description and Business Overview
12.4.3 Biopharmaceutical Introduction
12.4.4 Sanofi-Aventis Revenue in Biopharmaceutical Business (2014-2019)
12.4.5 Sanofi-Aventis Recent Development
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Company Details
12.5.2 Company Description and Business Overview
12.5.3 Biopharmaceutical Introduction
12.5.4 Johnson & Johnson Revenue in Biopharmaceutical Business (2014-2019)
12.5.5 Johnson & Johnson Recent Development
12.6 Pfizer
12.6.1 Pfizer Company Details
12.6.2 Company Description and Business Overview
12.6.3 Biopharmaceutical Introduction
12.6.4 Pfizer Revenue in Biopharmaceutical Business (2014-2019)
12.6.5 Pfizer Recent Development
12.7 Novo Nordisk
12.7.1 Novo Nordisk Company Details
12.7.2 Company Description and Business Overview
12.7.3 Biopharmaceutical Introduction
12.7.4 Novo Nordisk Revenue in Biopharmaceutical Business (2014-2019)
12.7.5 Novo Nordisk Recent Development
12.8 Eli Lilly
12.8.1 Eli Lilly Company Details
12.8.2 Company Description and Business Overview
12.8.3 Biopharmaceutical Introduction
12.8.4 Eli Lilly Revenue in Biopharmaceutical Business (2014-2019)
12.8.5 Eli Lilly Recent Development
12.9 Novartis
12.9.1 Novartis Company Details
12.9.2 Company Description and Business Overview
12.9.3 Biopharmaceutical Introduction
12.9.4 Novartis Revenue in Biopharmaceutical Business (2014-2019)
12.9.5 Novartis Recent Development
12.10 Merck
12.10.1 Merck Company Details
12.10.2 Company Description and Business Overview
12.10.3 Biopharmaceutical Introduction
12.10.4 Merck Revenue in Biopharmaceutical Business (2014-2019)
12.10.5 Merck Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details